Phase III Analyses Prompt Partial Clinical Hold On Oncopeptides' Melflufen Studies

OCEAN OS Data Favors Active Comparator

 
• By John Davis
  
multiple myeloma
• Source: Alamy

More from Anticancer

More from Therapy Areas